<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03916770</url>
  </required_header>
  <id_info>
    <org_study_id>IstPMRTRH-BMR</org_study_id>
    <nct_id>NCT03916770</nct_id>
  </id_info>
  <brief_title>The Effect of Whole Body Vibration (WBV) on Spasticity in Poststroke Hemiplegia</brief_title>
  <acronym>WBV</acronym>
  <official_title>The Effect of Whole Body Vibration on Spasticity in Poststroke Hemiplegia:Prospective Randomized Controlled Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to show whether WBV application has antispastic effect.
      The secondary aim is to demonstrate whether WBV has neuromodulatory activity on increased
      stretch reflex and motor neuron activity, which is the basis of the pathophysiology of
      spasticity.Hypotheses of this study:Whole body vibration in poststroke hemiplegia reduces
      ankle plantar flexion spasticity.

        1. WBV ; reduces plantar flexor spasticity after stroke

        2. WBV decreases poststroke spasticity, by decreasing increased stretch reflex and motor
           neuron activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with a stroke of at least 1 month before and with a history of ankle plantar flexion
      spasticity will be included in the study. Conventional rehabilitation program will be applied
      to all patients (n=48).The intervention group (n=24) will be applied for 4 weeks, 2 days a
      week, a total of 8 sessions with the WBV powerplate pro5 device.(Vibration frequency: 30
      Hertz(Hz), amplitude: 2.2 mm and duration 1x10 seconds (starting period) + 3x30 seconds).The
      Sham control group (n=24) will have 8 sessions WBV in total, the same time,.with the same
      frequency but 99.5% weakened amplitude.The surface Electromyography (EMG) and degree of
      spasticity of soleus muscle will be evaluated at the beginning and end of the all sessions.
      Soleus T-reflex and soleus H-reflex will be recorded with surface EMG.To obtain the H-reflex
      response, the posterior tibial nerve in the popliteal region will be stimulated by using a
      stimulator (FE155 Stimulator HC ADInstrument, Oxford UK) with 1 ms-pulse current. The records
      will be taken with the Ag / AgCl electrodes (Kendall ®Coviden, self-adhesive electrodes)
      placed on skin according to the SENIAM protocol. To obtain T reflex response, an electronic
      reflex hammer (Elcon 100-150 Germany) will be used.The degree of spasticity will be measured
      as a soleus muscle tone torque on a fixed angular velocity moving platform.The data will be
      recorded with the PowerLab data acquisition device
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Whole Body Vibration (WBV) will be applied to Poststroke Hemiplegia. The patients are divided in two groups; WBV group and shame WBV group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients will be blind to treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Spasticity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Spasticity will be measured as a torque. The unit is Nm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor neuron activity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Hmax / Mmax ratio defines motor neuron activity. The higher this ratio, the higher the activity of motor neuron pool.
• Soleus muscle stretch reflex activity (Soleus T-reflex and H reflex responses)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle stretch reflex activity</measure>
    <time_frame>4 weeks</time_frame>
    <description>A stretch reflex activity is determined by measuring the T reflex and H reflex amplitude. The amplitude unit will be mA.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Muscle Spasticity</condition>
  <condition>Physiology</condition>
  <arm_group>
    <arm_group_label>whole body vibration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>WBV(whole body vibration) will be applied to interventional group for 4 weeks, 2 days a week, a total of 8 sessions while standing upright with the WBV powerplate pro5 device.(Vibration frequency: 30Hz, amplitude: 2.2 mm and duration 1x10 seconds (starting period) + 3x30 seconds).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham whole body vibration</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham WBV will be applied to the Control group. A WBV device with 99.5% weakened amplitude will be used for sham WBV. (Application duration of the sham WBV will be 1x10 seconds (starting period) + 3x30 seconds).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham vibrator</intervention_name>
    <description>The Sham control group will have WBV the same time,in the same position with the same frequency but 99.5% weakened amplitude.</description>
    <arm_group_label>Sham whole body vibration</arm_group_label>
    <other_name>Sham WBV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real vibrator</intervention_name>
    <description>The intervention group will have WBV(frequency:30Hz,amplitude:2,2mm,at upright position</description>
    <arm_group_label>whole body vibration</arm_group_label>
    <other_name>Real WBV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ischemic / hemorrhagic poststroke hemiplegia

          2. Stroke time ≥1 months,

          3. Ankle plantar flexor spasticity MAS ≥1,

          4. Brunnstrom stage ≥3 for lower extremity,

          5. Patients who were standing for more than one minute and had a static balance

        Exclusion Criteria:

          1. Cardiac disorder (rhythm / conduction disorder, cardiac pacemaker, ischemic heart
             disease)

          2. The presence of lower extremity fracture,

          3. Findings or suspicion of active deep vein thrombosis,

          4. A history of deep vein thrombosis and pulmonary embolism,

          5. Orthostatic hypotension

          6. Resistant hypertension,

          7. Peripheral nerve lesions such as polyneuropathy, radiculopathy

          8. Active inflammatory, rheumatologic or infectious disease,

          9. Having joint contracture,

         10. Having a history of panic attacks,

         11. Patients with dizziness and balance problems,

         12. Patients with not intact skin surface to connect electrodes

         13. Patients with communication problems: aphasia, major depression

         14. Epilepsy

         15. Patients who received botulinum A toxin in the last 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayşenur Bardak, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zeynep Yurttutmuş, MD</last_name>
    <phone>+905533167877</phone>
    <email>zynpyurttutmus@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul Physical Medicine Rehabilitation Training and Research Hospital Istanbul, Turkey</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeynep Yurttutmuş, MD</last_name>
      <phone>+905533167877</phone>
      <email>zynpyurttutmus@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Chan KS, Liu CW, Chen TW, Weng MC, Huang MH, Chen CH. Effects of a single session of whole body vibration on ankle plantarflexion spasticity and gait performance in patients with chronic stroke: a randomized controlled trial. Clin Rehabil. 2012 Dec;26(12):1087-95. doi: 10.1177/0269215512446314. Epub 2012 Oct 3.</citation>
    <PMID>23035004</PMID>
  </reference>
  <reference>
    <citation>Pang MY, Lau RW, Yip SP. The effects of whole-body vibration therapy on bone turnover, muscle strength, motor function, and spasticity in chronic stroke: a randomized controlled trial. Eur J Phys Rehabil Med. 2013 Aug;49(4):439-50. Epub 2013 Mar 13.</citation>
    <PMID>23486302</PMID>
  </reference>
  <reference>
    <citation>Miyara K, Matsumoto S, Uema T, Noma T, Ikeda K, Ohwatashi A, Kiyama R, Shimodozono M. Effect of whole body vibration on spasticity in hemiplegic legs of patients with stroke. Top Stroke Rehabil. 2018 Mar;25(2):90-95. doi: 10.1080/10749357.2017.1389055. Epub 2017 Oct 16.</citation>
    <PMID>29032720</PMID>
  </reference>
  <reference>
    <citation>Brogårdh C, Flansbjer UB, Lexell J. No specific effect of whole-body vibration training in chronic stroke: a double-blind randomized controlled study. Arch Phys Med Rehabil. 2012 Feb;93(2):253-8. doi: 10.1016/j.apmr.2011.09.005.</citation>
    <PMID>22289234</PMID>
  </reference>
  <reference>
    <citation>Alp A, Efe B, Adalı M, Bilgiç A, Demir Türe S, Coşkun Ş, Karabulut M, Ertem U, Günay SM. The Impact of Whole Body Vibration Therapy on Spasticity and Disability of the Patients with Poststroke Hemiplegia. Rehabil Res Pract. 2018 May 2;2018:8637573. doi: 10.1155/2018/8637573. eCollection 2018.</citation>
    <PMID>30225145</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 11, 2019</study_first_submitted>
  <study_first_submitted_qc>April 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>muscle</keyword>
  <keyword>vibration</keyword>
  <keyword>H reflex</keyword>
  <keyword>H/M ratio</keyword>
  <keyword>spasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Hemiplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

